Evidence map›Paper›PMID 41196146›Full record

ArticleAntimicrobial agents and chemotherapy2025

Clinical emergence of inducible macrolide resistance mediated by acquired

Guiqing He, Shushu Zeng, Lilla Terezia Banki, Wenzhen Zhou, Qingyong Zheng, Quelu Chen, Xiaoyan Yang, Jie Luo, Jiajun Pan, Tao Luo

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Guiqing He *Department of Infectious Diseases, Wenzhou Central Hospital, The Dingli Clinical College of Wenzhou Medical University, Wenzhou, China.ORCID 0000-0002-6700-6920
Shushu Zeng *Department of Pathogen Biology, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, China.
Lilla Terezia BankiDepartment of Pathogen Biology, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, China.
Wenzhen ZhouDepartment of Infectious Diseases, Wenzhou Central Hospital, The Dingli Clinical College of Wenzhou Medical University, Wenzhou, China.
Qingyong ZhengLaboratory of Infectious Diseases, Wenzhou Central Hospital, The Dingli Clinical College of Wenzhou Medical University, Wenzhou, China.
Quelu ChenDepartment of Radiology, Wenzhou Central Hospital, The Dingli Clinical College of Wenzhou Medical University, Wenzhou, China.
Xiaoyan YangDepartment of Pathogen Biology, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, China.
Jie LuoDepartment of Pathogen Biology, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, China.
Jiajun PanDepartment of Pathogen Biology, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, China.
Tao LuoDepartment of Pathogen Biology, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, China.ORCID 0000-0002-2929-2233

Funding

Medicine and Health Plan Project of Zhejiang Province 2024KY393National Natural Science Foundation of China 32070135Wenzhou Science and Technology Plan Project Y20220030
6 · The paper itself

Abstract

Inducible macrolide resistance mediated by the

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialMacrolidesMethyltransferasesMycobacterium abscessusMycobacterium Infections, NontuberculousHumansMicrobial Sensitivity TestsPoint MutationAnti-Bacterial AgentsMacrolidesMethyltransferasesadaptive mutationsmacrolide resistanceMycobacterium abscessusribosomal methyltransferase

Identifiers

PMID41196146
PMCPMC12691619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.